Birdwatch Note Rating
2024-05-19 06:14:13 UTC - HELPFUL
Rated by Participant: DE0AA57942DB039BAFD9AD18734AD90A1349C8F0817DBEE552010C40C416C92E
Participant Details
Original Note:
No, the Ebola clinical trial involving the COVID-19 drug Remdesivir did not show Remdesivir had a 50% mortality rate. This is a false interpretation of the study. The study showed that Ebola infection had a 53% mortality rate. Ebola can have up to a 90% mortality rate https://nejm.org/doi/full/10.1056/nejmoa1910993 https://paho.org/en/topics/ebola-virus-disease
All Note Details